Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
|
|
ELITE PHARMACEUTICALS INC (ELTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/31/2023 |
10-K/A
| Annual Report for the period ended March 31, 2023 [amend] |
| 07/17/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
| 06/29/2023 |
8-K
| Quarterly results |
| 06/29/2023 |
10-K
| Annual Report for the period ended March 31, 2023 |
| 05/08/2023 |
3
| Pellegrino Mark N (CFO, Secretary, Treasurer) has filed a Form 3 on ELITE PHARMACEUTICALS INC /NV/ |
| 05/03/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
8-K
| Quarterly results |
| 02/28/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
8-K
| Quarterly results |
| 12/22/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 11/28/2022 |
8-K
| Quarterly results |
| 11/15/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
8-K
| Quarterly results |
| 11/02/2022 |
8-K
| Quarterly results |
| 09/13/2022 |
3
| Kirkov Kirko (Chief Commercial Officer) has filed a Form 3 on ELITE PHARMACEUTICALS INC /NV/ |
| 09/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 08/29/2022 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 459,536 shares
@ $0.0435, valued at
$20k
|
|
| 08/29/2022 |
4
| Caskey Davis S (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 459,536 shares
@ $0.0435, valued at
$20k
|
|
| 08/29/2022 |
4
| Dash Barry H (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 459,536 shares
@ $0.0435, valued at
$20k
|
|
| 08/26/2022 |
8-K
| Termination of a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 08/15/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/07/2022 |
4
| Chen Robert C J (CFO, Secretary, Treasurer) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 900,000 options
@ $0.04, valued at
$36k
|
|
| 06/29/2022 |
8-K
| Quarterly results |
| 06/29/2022 |
10-K
| Annual Report for the period ended March 31, 2022 |
| 06/29/2022 |
8-K
| Quarterly results |
| 06/03/2022 |
3
| Chen Robert C J (CFO, Secretary, Treasurer) has filed a Form 3 on ELITE PHARMACEUTICALS INC /NV/ |
| 05/11/2022 |
8-K
| Quarterly results |
| 04/18/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/04/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
|
|
|